DocWire News Editors

DocwireNews

<p><em>DocWire News rounds up this week&rsquo;s cardiology stories. Click on the articles and links below to read.</em><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/myocardial-infarction-blood-pressure-monitoring-smartphone/">Does Monitoring Using a Smartphone Help with Post-MI Blood Pressure Control?</a></h2><p>This<a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2764578?utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_term=041620"> <em>JAMA Network Open</em> </a>study examined whether blood pressure control following a myocardial infarction was helped by tracking with a smartphone application. The 200 patients enrolled from a single center had ST-segment elevation myocardial infarction (STEMI) or non-ST-segment acute coronary syndrome. Patients were randomized 1:1 to either using smart technology or usual care during follow-up. After one year, 79% of patients in the intervention group had controlled blood pressure compared with 76% in the usual care group (not statistically significant).</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/myocardial-infarction-blood-pressure-monitoring-smartphone/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/afib-atrial-fibrillation-icd-outcomes-implantable-defibrillator/">Baseline AFib Linked with Eventual ICD Outcomes: Study</a></h2><p>This <a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/pace.13919"><em>Pacing and Clinical Electrophysiology</em></a> study included more than 500 patients who received an implantable cardioverter defibrillator (ICD) for the first time. A multivariate analysis revealed that the clinical factors associated with a baseline history of AFib included hypertension, valvular heart disease, body weight, PR interval, and serum creatinine level. &ldquo;Among first&#8208;time ICD recipients, specific clinical characteristics were associated with a baseline history of AFib at the time of ICD implant, the authors concluded. &ldquo;After adjustment for potential confounders, a baseline history of AFib was associated with a higher risk of all ICD therapies in follow&#8208;up.&rdquo;</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/afib-atrial-fibrillation-icd-outcomes-implantable-defibrillator/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/oral-anticoagulants-warfarin-ischemic-stroke-systemic-emboli/">Off-label Anticoagulant Use for LV Thrombi Carries Stroke Risk</a></h2><p>A new <a href="https://jamanetwork.com/journals/jamacardiology/article-abstract/2764434"><em>JAMA Cardiology</em></a> study looked at the off-label use of direct oral anticoagulants and their potential effects for helping treat left ventricular (LV) thrombi. The study included more then 500 eligible patients diagnosed with LV thrombi. According to the results, 300 patients received warfarin and 185 received direct oral anticoagulants (with 64 switching between treatment groups). Median follow-up was 351 days. According to the unadjusted analysis, the use of direct oral anticoagulants (compared with warfarin) and prior SSE were both significantly associated with SSE.</p><p>https://www.docwirenews.com/docwire-pick/cardiology-picks/oral-anticoagulants-warfarin-ischemic-stroke-systemic-emboli/</p><p>&ndash;</p><h2><a href="https://www.docwirenews.com/cardiology/women-receive-fewer-recommended-medications-post-heart-attack/">Women Who Survive Heart Attacks Less Likely to Be Given All Appropriate Medication</a></h2><p>New <a href="http://www.escardio.org/acvcessentials4u">research</a> from the European Society of Cardiology suggests that many women who survive heart attacks are not given all of the recommended medications they should be receiving. The study included more than 1,500 participants. the authors&nbsp;reported that 55% of women in the study (compared with 64% of men) had received optimal medical therapy at follow-up, and also that women were less likely to undergo invasive procedures compared to men (71% vs. 83%, respectively). Multivariable regression analysis revealed that optimal medical therapy after a heart attack was independently associated with an almost 50% decrease in the risk for all-cause death. Female sex, however, was not an independent predictor of death</p></p>


Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Cardio Round-up: Smartphones for BP Control, AFib and ICD Outcomes, and More

Atrial Fibrillation

DocWire News rounds up this week's cardiology stories. Click on the articles and links below to read. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe